Application of SILCS to potassium channel hERG1 read more here.

News2022-06-08T02:20:42+00:00

SilcsBio Spinout Raises $1.5 Million Investment

FOR IMMEDIATE RELEASE:   SilcsBio Spinout Raises $1.5 Million to Advance Drug Development New investment from Bluedot Bio into Rasio follows initial funding from the National Foundation for Cancer Research   December 2, 2021, Baltimore, MD – Rasio Therapeutics, a joint venture formed by SilcsBio and the National Foundation for [...]

December 2nd, 2021|

SilcsBio Announces Hiring of KC Song as Full Stack Developer

Song will focus on web applications development and solutions to help drive SilcsBio’s continued growth September 28, 2021, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced the hiring of KC Song as Full Stack Developer. Song joins the [...]

November 30th, 2021|

SilcsBio Announces Hiring of Ankita Katiyar, PhD as Application Scientist

Katiyar will focus on fueling product and technology development for SilcsBio August 24, 2021, Baltimore, MD – – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced the hiring of Ankita Katiyar, PhD as Applications Scientist focusing on product development. Katiyar – [...]

November 30th, 2021|

SilcsBio Awarded $1,760,531 in SBIR Phase II Funding from the National Institutes of Health

SilcsBio will leverage the award to extend its commercially available software from small molecule design to the design of biological therapeutics November 16, 2021, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced it has been awarded a $1,760,531 Small [...]

November 16th, 2021|

Aikido Provides Update on Use of Machine Learning in Drug Development Program

FOR IMMEDIATE RELEASE: Aikido Provides Update on Use of Machine Learning in Drug Development Program NEW YORK, NY August    , 2021 /PRNewswire/ AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today provided and update on the use of Machine Learning in support of its antiviral platform with the University [...]

August 10th, 2021|

Job Opening: Scientific Programmer

SilcsBio's parent company, Early Charm, has a job opening to work with SilcsBio and other companies in its Drug Design Portfolio.   Immediate Job Opening   Scientific Programmer   July 27, 2021   What we do: Early Charm creates, owns, and operates businesses that convert science into revenue. We are [...]

July 27th, 2021|
Go to Top